DERIVES DE QUINOLEINE UTILISES COMME INHIBITEURS DE RTK DE TAM

• 收藏
• 分享

专利权人:

QURIENT CO., LTD;QURIENT CO.; LTD;LEAD DISCOVERY CENTER GMBH

发明人:

NAM, KIYEAN,KIM, JAESEUNG,AHN, SEOHYUN,JEON, YEEJIN,LEE, DOOHYUNG,PARK, DONGSIK,YANG, YOUNG-IN,LEE, SAEYEON,KIM, JEONGJUN,AHN, JIYE,KIM, HANA,JUNG, CHUN-WON,SCHULTZ-FADEMRECHT, CARSTEN

申请号：

CA2980652

公开号：

CA2980652A1

申请日:

2016.04.14

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention relates to novel compounds which are inhibitors of TAM (Axl, Mer and Tyro 3) and/or Met family receptor tyrosine kinases (RTKs). These compounds are suitable for the treatment of disorders associated with, accompanied by, caused by or induced by a receptor of the TAM family, in particular a hyperfunction thereof. The compounds are suitable for the treatment of hyperproliferative disorders, such as cancer, particularly immune-suppressive cancer, refractory cancer and cancer metastases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/